WO2012163078A1 - 一种近红外硫化银量子点、其制备方法及其生物应用 - Google Patents
一种近红外硫化银量子点、其制备方法及其生物应用 Download PDFInfo
- Publication number
- WO2012163078A1 WO2012163078A1 PCT/CN2012/000167 CN2012000167W WO2012163078A1 WO 2012163078 A1 WO2012163078 A1 WO 2012163078A1 CN 2012000167 W CN2012000167 W CN 2012000167W WO 2012163078 A1 WO2012163078 A1 WO 2012163078A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- silver
- sulfide quantum
- silver sulfide
- quantum dot
- infrared
- Prior art date
Links
- 239000002096 quantum dot Substances 0.000 title claims abstract description 67
- 229910052946 acanthite Inorganic materials 0.000 title claims abstract description 27
- XUARKZBEFFVFRG-UHFFFAOYSA-N silver sulfide Chemical compound [S-2].[Ag+].[Ag+] XUARKZBEFFVFRG-UHFFFAOYSA-N 0.000 title claims abstract description 27
- 229940056910 silver sulfide Drugs 0.000 title claims abstract description 27
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 238000006243 chemical reaction Methods 0.000 claims abstract description 25
- PGWMQVQLSMAHHO-UHFFFAOYSA-N sulfanylidenesilver Chemical class [Ag]=S PGWMQVQLSMAHHO-UHFFFAOYSA-N 0.000 claims abstract description 22
- CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 13
- 125000003396 thiol group Chemical class [H]S* 0.000 claims abstract description 9
- 238000003384 imaging method Methods 0.000 claims abstract description 8
- UFULAYFCSOUIOV-UHFFFAOYSA-N cysteamine Chemical compound NCCS UFULAYFCSOUIOV-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229960003151 mercaptamine Drugs 0.000 claims abstract description 6
- DKIDEFUBRARXTE-UHFFFAOYSA-N 3-mercaptopropanoic acid Chemical compound OC(=O)CCS DKIDEFUBRARXTE-UHFFFAOYSA-N 0.000 claims abstract description 5
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims abstract description 5
- ZZTCCAPMZLDHFM-UHFFFAOYSA-N ammonium thioglycolate Chemical compound [NH4+].[O-]C(=O)CS ZZTCCAPMZLDHFM-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000002253 acid Substances 0.000 claims abstract description 3
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims abstract description 3
- 235000018417 cysteine Nutrition 0.000 claims abstract description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 22
- 238000000034 method Methods 0.000 claims description 22
- 230000002209 hydrophobic effect Effects 0.000 claims description 21
- 150000003573 thiols Chemical class 0.000 claims description 18
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 13
- 229910052709 silver Inorganic materials 0.000 claims description 13
- 239000004332 silver Substances 0.000 claims description 13
- 239000003495 polar organic solvent Substances 0.000 claims description 7
- 239000004094 surface-active agent Substances 0.000 claims description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 claims description 6
- 238000005406 washing Methods 0.000 claims description 6
- PMBXCGGQNSVESQ-UHFFFAOYSA-N 1-Hexanethiol Chemical compound CCCCCCS PMBXCGGQNSVESQ-UHFFFAOYSA-N 0.000 claims description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 4
- 229940075861 ammonium thioglycolate Drugs 0.000 claims description 4
- 238000005119 centrifugation Methods 0.000 claims description 4
- WNAHIZMDSQCWRP-UHFFFAOYSA-N dodecane-1-thiol Chemical compound CCCCCCCCCCCCS WNAHIZMDSQCWRP-UHFFFAOYSA-N 0.000 claims description 4
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 claims description 4
- ORTRWBYBJVGVQC-UHFFFAOYSA-N hexadecane-1-thiol Chemical compound CCCCCCCCCCCCCCCCS ORTRWBYBJVGVQC-UHFFFAOYSA-N 0.000 claims description 4
- HKZPVMJAYKCGAT-UHFFFAOYSA-N benzenecarbothioic s-acid;silver Chemical compound [Ag].SC(=O)C1=CC=CC=C1 HKZPVMJAYKCGAT-UHFFFAOYSA-N 0.000 claims description 3
- UZZYXUGECOQHPU-UHFFFAOYSA-M n-octyl sulfate Chemical compound CCCCCCCCOS([O-])(=O)=O UZZYXUGECOQHPU-UHFFFAOYSA-M 0.000 claims description 3
- KZCOBXFFBQJQHH-UHFFFAOYSA-N octane-1-thiol Chemical compound CCCCCCCCS KZCOBXFFBQJQHH-UHFFFAOYSA-N 0.000 claims description 3
- 229940067739 octyl sulfate Drugs 0.000 claims description 3
- 229910001961 silver nitrate Inorganic materials 0.000 claims description 3
- NSVHDIYWJVLAGH-UHFFFAOYSA-M silver;n,n-diethylcarbamodithioate Chemical compound [Ag+].CCN(CC)C([S-])=S NSVHDIYWJVLAGH-UHFFFAOYSA-M 0.000 claims description 3
- UZZYXUGECOQHPU-UHFFFAOYSA-N sulfuric acid monooctyl ester Natural products CCCCCCCCOS(O)(=O)=O UZZYXUGECOQHPU-UHFFFAOYSA-N 0.000 claims description 3
- AHKKAMCTCDIBES-UHFFFAOYSA-N 1,4-dioctoxy-1,4-dioxobutane-2-sulfonic acid;silver Chemical compound [Ag].CCCCCCCCOC(=O)CC(S(O)(=O)=O)C(=O)OCCCCCCCC AHKKAMCTCDIBES-UHFFFAOYSA-N 0.000 claims description 2
- SRZXCOWFGPICGA-UHFFFAOYSA-N 1,6-Hexanedithiol Chemical compound SCCCCCCS SRZXCOWFGPICGA-UHFFFAOYSA-N 0.000 claims description 2
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims description 2
- -1 ^- thiol Chemical compound 0.000 claims description 2
- 150000003973 alkyl amines Chemical class 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 229960002433 cysteine Drugs 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 claims description 2
- 235000019136 lipoic acid Nutrition 0.000 claims description 2
- QJAOYSPHSNGHNC-UHFFFAOYSA-N octadecane-1-thiol Chemical compound CCCCCCCCCCCCCCCCCCS QJAOYSPHSNGHNC-UHFFFAOYSA-N 0.000 claims description 2
- 239000002798 polar solvent Substances 0.000 claims description 2
- CQLFBEKRDQMJLZ-UHFFFAOYSA-M silver acetate Chemical compound [Ag+].CC([O-])=O CQLFBEKRDQMJLZ-UHFFFAOYSA-M 0.000 claims description 2
- 229940071536 silver acetate Drugs 0.000 claims description 2
- ORYURPRSXLUCSS-UHFFFAOYSA-M silver;octadecanoate Chemical compound [Ag+].CCCCCCCCCCCCCCCCCC([O-])=O ORYURPRSXLUCSS-UHFFFAOYSA-M 0.000 claims description 2
- OHGHHPYRRURLHR-UHFFFAOYSA-M silver;tetradecanoate Chemical compound [Ag+].CCCCCCCCCCCCCC([O-])=O OHGHHPYRRURLHR-UHFFFAOYSA-M 0.000 claims description 2
- GEKDEMKPCKTKEC-UHFFFAOYSA-N tetradecane-1-thiol Chemical compound CCCCCCCCCCCCCCS GEKDEMKPCKTKEC-UHFFFAOYSA-N 0.000 claims description 2
- 229960002663 thioctic acid Drugs 0.000 claims description 2
- IPBROXKVGHZHJV-UHFFFAOYSA-N tridecane-1-thiol Chemical compound CCCCCCCCCCCCCS IPBROXKVGHZHJV-UHFFFAOYSA-N 0.000 claims description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims 2
- PWKSKIMOESPYIA-UHFFFAOYSA-N 2-acetamido-3-sulfanylpropanoic acid Chemical compound CC(=O)NC(CS)C(O)=O PWKSKIMOESPYIA-UHFFFAOYSA-N 0.000 claims 1
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 claims 1
- 150000001298 alcohols Chemical class 0.000 claims 1
- 235000019260 propionic acid Nutrition 0.000 claims 1
- 229940095574 propionic acid Drugs 0.000 claims 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims 1
- 230000001413 cellular effect Effects 0.000 abstract 1
- 230000002349 favourable effect Effects 0.000 abstract 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 72
- 239000000243 solution Substances 0.000 description 34
- 239000011259 mixed solution Substances 0.000 description 19
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 12
- 239000002245 particle Substances 0.000 description 12
- 239000006228 supernatant Substances 0.000 description 12
- 229940082789 erbitux Drugs 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 229910000530 Gallium indium arsenide Inorganic materials 0.000 description 6
- 229910052782 aluminium Inorganic materials 0.000 description 6
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 6
- 239000011888 foil Substances 0.000 description 6
- 238000012986 modification Methods 0.000 description 6
- 230000004048 modification Effects 0.000 description 6
- 239000008367 deionised water Substances 0.000 description 5
- 229910021641 deionized water Inorganic materials 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 238000002189 fluorescence spectrum Methods 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 239000012298 atmosphere Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000006557 surface reaction Methods 0.000 description 3
- 238000002441 X-ray diffraction Methods 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 231100000053 low toxicity Toxicity 0.000 description 2
- 230000006911 nucleation Effects 0.000 description 2
- 238000010899 nucleation Methods 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- QGLWBTPVKHMVHM-KTKRTIGZSA-N (z)-octadec-9-en-1-amine Chemical compound CCCCCCCC\C=C/CCCCCCCCN QGLWBTPVKHMVHM-KTKRTIGZSA-N 0.000 description 1
- PGTWZHXOSWQKCY-UHFFFAOYSA-N 1,8-Octanedithiol Chemical compound SCCCCCCCCS PGTWZHXOSWQKCY-UHFFFAOYSA-N 0.000 description 1
- FJLUATLTXUNBOT-UHFFFAOYSA-N 1-Hexadecylamine Chemical compound CCCCCCCCCCCCCCCCN FJLUATLTXUNBOT-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 1
- 235000013878 L-cysteine Nutrition 0.000 description 1
- 239000004201 L-cysteine Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- REYJJPSVUYRZGE-UHFFFAOYSA-N Octadecylamine Chemical compound CCCCCCCCCCCCCCCCCCN REYJJPSVUYRZGE-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 238000003917 TEM image Methods 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- VTXVGVNLYGSIAR-UHFFFAOYSA-N decane-1-thiol Chemical compound CCCCCCCCCCS VTXVGVNLYGSIAR-UHFFFAOYSA-N 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- JRBPAEWTRLWTQC-UHFFFAOYSA-N dodecylamine Chemical compound CCCCCCCCCCCCN JRBPAEWTRLWTQC-UHFFFAOYSA-N 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000001215 fluorescent labelling Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011503 in vivo imaging Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 229910052745 lead Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- MNMYRUHURLPFQW-UHFFFAOYSA-M silver;dodecanoate Chemical compound [Ag+].CCCCCCCCCCCC([O-])=O MNMYRUHURLPFQW-UHFFFAOYSA-M 0.000 description 1
- LTYHQUJGIQUHMS-UHFFFAOYSA-M silver;hexadecanoate Chemical compound [Ag+].CCCCCCCCCCCCCCCC([O-])=O LTYHQUJGIQUHMS-UHFFFAOYSA-M 0.000 description 1
- FSJWWSXPIWGYKC-UHFFFAOYSA-M silver;silver;sulfanide Chemical class [SH-].[Ag].[Ag+] FSJWWSXPIWGYKC-UHFFFAOYSA-M 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 231100000701 toxic element Toxicity 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000004627 transmission electron microscopy Methods 0.000 description 1
- ZMBHCYHQLYEYDV-UHFFFAOYSA-N trioctylphosphine oxide Chemical compound CCCCCCCCP(=O)(CCCCCCCC)CCCCCCCC ZMBHCYHQLYEYDV-UHFFFAOYSA-N 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/02—Use of particular materials as binders, particle coatings or suspension media therefor
- C09K11/025—Use of particular materials as binders, particle coatings or suspension media therefor non-luminescent particle coatings or suspension media
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
- A61K49/0065—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the luminescent/fluorescent agent having itself a special physical form, e.g. gold nanoparticle
- A61K49/0067—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the luminescent/fluorescent agent having itself a special physical form, e.g. gold nanoparticle quantum dots, fluorescent nanocrystals
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
- C01G5/00—Compounds of silver
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
- C07F1/005—Compounds containing elements of Groups 1 or 11 of the Periodic Table without C-Metal linkages
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/08—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
- C09K11/58—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing copper, silver or gold
- C09K11/582—Chalcogenides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/588—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with semiconductor nanocrystal label, e.g. quantum dots
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
Definitions
- the present invention relates to the field of materials chemistry and biology, and in particular, to a near-infrared silver sulfide quantum dot, a process for its preparation, and a biological application thereof. Background technique
- N-infrared quantum dot fluorescence imaging technology has many unique features in living level imaging. Advantages, such as deep penetration of tissue, can overcome the defects of visible quantum dots that are susceptible to background fluorescence during deep tissue imaging. Therefore, it has attracted widespread attention in medical diagnostics, molecular biology, and cell biology.
- the currently common near-infrared quantum dots contain toxic elements such as Cd, Hg, and Pb.
- Object of the present invention is to overcome the above problems is provided a near-infrared silver sulfide quantum dot, the near infrared Ag 2 S quantum dots have a high fluorescence yield, fluorescence stability, uniform scale, and simple preparation process, and by Surface functionalization also has good biocompatibility and can be applied to bioimaging.
- the surface of the silver sulfide quantum dot is bonded with a hydrophilic group derived from a mercapto group-containing hydrophilic reagent, and the hydrophilic reagent is mercaptoacetic acid, mercaptopropionic acid, and a half. Any one or a combination of two or more of cystine, cysteamine, octylsulfate, and ammonium thioglycolate. It is still another object of the present invention to provide a method of preparing near-infrared silver sulfide quantum dots in order to overcome the above problems, the method comprising the steps of:
- the hydrophobic silver sulfide quantum dots in the step 1) reacting with an equal or excess amount of the thiol-containing hydrophilic reagent in a polar organic solvent to form a hydrophilic group on the surface thereof to obtain a near-infrared Silver sulfide quantum dots; in the present invention, as long as the number of moles of the thiol-containing hydrophilic agent is greater than or equal to the hydrophobic silver sulfide quantum dots, the prepared hydrophilic silver sulfide quantum dots have a good effect.
- the ratio can be adjusted according to actual needs during the preparation process, but the objects of the present invention can be achieved.
- the hydrophilic agent is any one or a combination of two or more of thioglycolic acid, mercaptopropionic acid, cysteine, cysteamine, octylsulfate, and ammonium thioglycolate.
- the method for preparing a near-infrared silver sulfide quantum dot according to the present invention wherein the polar organic solvent in the step 2) comprises any one or more of ethanol, methanol, acetone, and 1-methyl-2-pyrrolidone.
- the organic solvent it is not limited to the organic solvent, and the pH of the hydrophobic silver sulfide quantum dot and the mercapto group-containing hydrophilic reagent mixed system in the step 2) is adjusted to be 7-14, and 2-80° in a polar organic solvent.
- the reaction under C is more than 3 hours.
- the prepared hydrophilic silver sulfide quantum dots have a good effect, and the ratio can be adjusted according to actual needs during the preparation process. Adjustments, but the objects of the invention can be achieved.
- the method for preparing the hydrophobic silver sulfide quantum dots in the step 1) comprises the following steps:
- the silver source comprises silver nitrate, silver diethyldithiocarbamate, silver dihydrocarbyl dithiophosphate, silver dioctyl sulfosuccinate, silver thiobenzoate, silver acetate, dodecanoic acid One or more of silver, silver tetradecanoate, and silver octadecanoate;
- the long-chain thiol includes octyl thiol, ⁇ - thiol, dodecyl mercaptan, tridecyl mercaptan, tetradecyl mercaptan, fifteen thiol, hexadecane thiol, octadecyl thiol, octathiol One or more of hexyl mercaptan, 1,6 hexanedithiol, and 1,8 octanedithiol.
- the mixed reaction system of the step 1-2) further includes a surfactant having a coordination property, and the surfactant is a long-chain alkyl group. Any one or a combination of two or more of an acid, an alkylamine, a long-chain alcohol, a long-chain thiol, and an ether;
- the reaction system is placed in a closed environment for reaction.
- the hydrophobic silver sulfide quantum dot and the mercapto group-containing hydrophilic reagent in the step 2) are polar organic at 2-80 V under continuous stirring and/or shaking and/or ultrasonication. The reaction was carried out in a solvent for 3 hours or more.
- the near-infrared silver sulfide quantum dots prepared by the method of the present invention have a monoclinic phase structure having a particle diameter of 8 nm or less.
- the invention adopts a silver source and a long-chain thiol as reactants, performs nucleation and growth in a reaction system in which surfactants having different coordination characteristics are present, and obtains a hydrophobic silver sulfide quantum dot, wherein the long-chain thiol provides sulfur
- the source can also be used as a solvent and a surfactant; then the prepared hydrophobic quantum dots are surface-functionalized with a thiol-containing hydrophilic agent, and since the sulfhydryl group and the silver have a good binding ability, it can replace the silver sulfide quantum dots.
- the Ag 2 S quantum dot first prepared in the present invention is in a superlattice state, and due to the particularity of the structure, if the prior art is used, The modified experimental conditions make it impossible to modify the hydrophobic Ag 2 S quantum dots into hydrophilic Ag 2 S quantum dots.
- the modification time has an important influence on the modification effect, which is a key experimental condition, and it is found that a better modification can be achieved when the modification time is 3 hours or more. Sexual effect, the longer the time, the better the modification effect. Therefore, the time can be adjusted according to actual needs during the preparation process, but the object of the present invention can be achieved as long as more than 3 hours, and the modified hydrophilicity
- the Ag 2 S quantum dots are monodisperse, do not agglomerate, have good hydrophilicity and stability, and can be used for cell imaging, especially for in vivo imaging.
- the process of the present invention is: using a silver source, a long-chain thiol and a suitable surfactant mixture, placed in a closed device, heated to a suitable temperature for a certain period of time, allowing it to grow nucleation; It is naturally cooled, centrifuged with excess ethanol, and washed to obtain hydrophobic silver sulfide quantum dots. Then, the prepared hydrophobic quantum dots, a certain amount of the thiol-containing hydrophilic agent and ethanol are mixed, stirred, shaken or ultrasonically allowed to fully react, and then washed with water to obtain a low toxicity and high biocompatibility. Fluorescence yield of near-infrared silver sulfide quantum dots, and finally cell imaging.
- optimization scheme of the foregoing technical solution may further include:
- the reaction uses different silver sources, different long-chain thiols, different surfactants, different reaction temperatures, different reaction times to adjust the size of silver sulfide nanoparticles, such as increasing temperature and prolonging the reaction. Time can make the particles bigger.
- the reaction can be modified according to the difference of different thiol-containing hydrophilic reagents, and the functionalized Ag 2 S quantum dots can be changed in aqueous solution by adjusting the pH value (better dispersion at alkaline 7-14). Dispersibility.
- the technical solution of the invention has the remarkable advantages that: the method of the invention has mild reaction conditions, simple operation, short preparation period, good repeatability and easy control, and the prepared Ag 2 S quantum dot fluorescence High yield, good fluorescence stability, good biocompatibility, and uniform size, can be used for imaging biological tissues including cells and in vivo.
- FIG. 1 is a transmission electron micrograph of hydrophobic Ag 2 S quantum dots of Example 1;
- Example 2 is a near-infrared fluorescence spectrum of a hydrophobic Ag 2 S quantum dot in Example 1;
- FIG 3 is a near-infrared fluorescence spectrum of Example 1.
- Figure 4 is a specific fluorescent photo of silver sulfide near-infrared quantum dots to cells
- Figure 5 is a specific labeled fluorescent photograph of silver sulfide near-infrared quantum dots on living tumors in mice. detailed description
- Quantum dots their fluorescence emission is still very strong; 0.25mg of the above Ag 2 S quantum dots are dispersed in ⁇ dimethyl sulfoxide (DMSO), and 50 DMSO solution containing 0.01 mmol NHS is mixed with the above solution; 50 DMSO solution containing 0.01 mmol EDC was added to the above mixed solution, wrapped in aluminum foil, stirred for 1 h, centrifuged, and dispersed in 100 DMSO; mixed with 15 2 mg/mL Erbitux and 185 LlxPBS The solution was added to a mixed solution of IjlOOuL Ag 2 S/DMSO, and reacted at 4 ° C for 12 h in the dark, then centrifuged at 400 g for 4 min, and the supernatant was taken; MDA-MB-468 cells were added to the above 100 supernatant and ⁇ The mixed solution of lxPBS was stained at 4 °C for 2 h, and then washed with lxPBS solution for 3 times. Using
- the method of the invention has mild reaction conditions, simple operation, short preparation period, good repeatability and easy control; the prepared Ag 2 S quantum dots have high fluorescence yield, good fluorescence stability and good biocompatibility. , uniform size, and can be well imaged by cells and animals; and it is easy to amplify the reaction, suitable for large-scale industrial production.
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Materials Engineering (AREA)
- Life Sciences & Earth Sciences (AREA)
- Inorganic Chemistry (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Nanotechnology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Luminescent Compositions (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12793905.6A EP2716733B1 (en) | 2011-05-30 | 2012-02-10 | Preparation method for near-infrared silver sulfide quantum dots |
RU2013152134/05A RU2576052C2 (ru) | 2011-05-30 | 2012-02-10 | Квантовые точки сульфида серебра, излучающие в ближней инфракрасной области спектра, способ их получения и применение в биологии |
US13/985,731 US20140087409A1 (en) | 2011-05-30 | 2012-02-10 | Near-infrared silver sulfide quantum dot, preparation method therefor and biological application thereof |
JP2014511707A JP5815126B2 (ja) | 2011-05-30 | 2012-02-10 | 近赤外硫化銀量子ドット、その調製方法と生物への適用 |
US14/955,736 US10421901B2 (en) | 2011-05-30 | 2015-12-01 | Preparation method of near-infrared silver sulfide quantum dots |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110142093.8 | 2011-05-30 | ||
CN201110142093.8A CN102277157B (zh) | 2011-05-30 | 2011-05-30 | 近红外硫化银量子点、其制备方法及其应用 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/985,731 A-371-Of-International US20140087409A1 (en) | 2011-05-30 | 2012-02-10 | Near-infrared silver sulfide quantum dot, preparation method therefor and biological application thereof |
US14/955,736 Continuation US10421901B2 (en) | 2011-05-30 | 2015-12-01 | Preparation method of near-infrared silver sulfide quantum dots |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2012163078A1 true WO2012163078A1 (zh) | 2012-12-06 |
Family
ID=45102899
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2012/000167 WO2012163078A1 (zh) | 2011-05-30 | 2012-02-10 | 一种近红外硫化银量子点、其制备方法及其生物应用 |
Country Status (6)
Country | Link |
---|---|
US (2) | US20140087409A1 (zh) |
EP (1) | EP2716733B1 (zh) |
JP (1) | JP5815126B2 (zh) |
CN (1) | CN102277157B (zh) |
RU (1) | RU2576052C2 (zh) |
WO (1) | WO2012163078A1 (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016024924A1 (en) | 2014-08-13 | 2016-02-18 | Koç Üni̇versi̇tesi̇ | Near-ir emitting cationic silver chalcogenide quantum dots |
CN110940718A (zh) * | 2019-12-10 | 2020-03-31 | 集美大学 | 一种近红外光电Ag2S@Au立方材料的制备和测试方法 |
CN111087011A (zh) * | 2019-12-16 | 2020-05-01 | 上海电力大学 | 一种硫化银量子点和硫化铟银量子点纳米材料的制备方法及其产品 |
WO2021070858A1 (ja) * | 2019-10-09 | 2021-04-15 | Nsマテリアルズ株式会社 | 量子ドット、及び、その製造方法 |
US11015115B2 (en) | 2015-12-31 | 2021-05-25 | 3M Innovative Properties Company | Curable quantum dot compositions and articles |
US11015114B2 (en) | 2015-12-31 | 2021-05-25 | 3M Innovative Properties Company | Article comprising particles with quantum dots |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102277157B (zh) * | 2011-05-30 | 2014-06-11 | 中国科学院苏州纳米技术与纳米仿生研究所 | 近红外硫化银量子点、其制备方法及其应用 |
CN102718248B (zh) * | 2012-06-13 | 2014-03-26 | 吉林大学 | 一步水相法制备近红外荧光性质的硫化银纳米晶的方法 |
CN102701265B (zh) * | 2012-06-21 | 2014-05-07 | 复旦大学 | 一种近红外发光的硫化银量子点的水相制备方法 |
CN102793533A (zh) * | 2012-08-09 | 2012-11-28 | 中国科学院苏州纳米技术与纳米仿生研究所 | 一种短波近红外量子点成像*** |
CN104288786B (zh) * | 2013-07-17 | 2017-02-22 | 中国科学院苏州纳米技术与纳米仿生研究所 | 基于近红外量子点的肿瘤靶向诊疗***及其制备方法 |
CN103454261B (zh) * | 2013-09-17 | 2015-09-23 | 桂林理工大学 | 一种利用拉曼光谱定量测定纳米微粒的方法 |
CN104046353B (zh) * | 2014-04-25 | 2015-09-23 | 安徽师范大学 | 用于荧光增强的组装物及其制备方法和应用 |
CN104655604B (zh) * | 2015-02-13 | 2017-11-03 | 安徽理工大学 | 一种用于检测氟离子的荧光传感器及其制备方法 |
WO2016182973A1 (en) * | 2015-05-08 | 2016-11-17 | Massachusetts Institute Of Technology | One-pot method for preparing core-shell nanocrystals |
CN106520123B (zh) * | 2016-02-25 | 2019-02-15 | 苏州影睿光学科技有限公司 | 一种银硒硫量子点纳米颗粒的制备方法 |
CN106053411B (zh) * | 2016-05-23 | 2019-02-19 | 中国科学院苏州生物医学工程技术研究所 | 基于硫化银量子点的miRNA检测方法 |
CN106398687B (zh) * | 2016-08-23 | 2018-09-28 | 华东师范大学 | 一种具有近红外发射性能的硫化银量子点溶胶的合成方法 |
CN106311293B (zh) * | 2016-10-19 | 2018-10-19 | 常州大学 | 一种硫代磷酸银/磷酸银催化剂的制备方法 |
CN106753344B (zh) * | 2016-11-25 | 2019-06-18 | 清华大学 | 硫化银量子点及其制备方法及应用 |
CN106442456B (zh) * | 2016-11-25 | 2019-02-05 | 清华大学 | 利用近红外二区荧光量子点探针检测锌离子的方法 |
CN106883847B (zh) * | 2017-01-20 | 2019-05-14 | 清华大学 | 一种近红外二区荧光量子点探针及制备方法和应用 |
CN106970212A (zh) * | 2017-04-11 | 2017-07-21 | 中南大学 | 一种近红外的电致化学发光免疫检测方法 |
CN108795409B (zh) * | 2017-04-28 | 2020-09-01 | 中国科学院苏州纳米技术与纳米仿生研究所 | 一种荧光金纳米团簇聚集体及其制备方法 |
CN107418562A (zh) * | 2017-09-06 | 2017-12-01 | 东北大学 | 近红外硫化银量子点的合成方法 |
CN107500339B (zh) * | 2017-09-21 | 2019-01-11 | 东华大学 | 一种近红外光的共掺杂硫化银纳米发光材料的制备方法 |
CN109932476B (zh) * | 2017-12-15 | 2022-05-24 | Tcl科技集团股份有限公司 | 一种量子点表面配体覆盖率的测定方法 |
CN108587599A (zh) * | 2018-03-28 | 2018-09-28 | 苏州星烁纳米科技有限公司 | 量子点分散体系 |
CN110628434A (zh) * | 2018-06-21 | 2019-12-31 | 首都师范大学 | 近红外发光材料在编码中的应用 |
CN110724525A (zh) * | 2018-07-16 | 2020-01-24 | 南京邮电大学 | 近红外二区荧光硫化银量子点的制备方法及硫化银量子点 |
CN109054812B (zh) * | 2018-08-24 | 2021-06-22 | 南京邮电大学 | 一种水相制备近红外二区荧光硫化银量子点的方法 |
CN109295697B (zh) * | 2018-09-12 | 2020-09-08 | 烟台明远智能家居科技有限公司 | 一种硫化银量子点复合二氧化钛溶胶对棉织物自清洁处理的方法 |
ES2773946B2 (es) * | 2019-01-15 | 2021-03-08 | Univ Madrid Complutense | Nanoparticulas de AG2S súper fluorescentes en la región del infrarrojo cercano y metódo de obtención |
CN109852379A (zh) * | 2019-03-13 | 2019-06-07 | 中国科学院苏州纳米技术与纳米仿生研究所 | 近红外ii区荧光量子点细胞膜标记***、标记方法及应用 |
CN110141208A (zh) * | 2019-04-12 | 2019-08-20 | 上海健康医学院 | 一种动态静态图像相结合的血流成像***和方法 |
CN111004628B (zh) * | 2019-12-24 | 2023-02-07 | 中国科学院苏州纳米技术与纳米仿生研究所 | 核壳结构硫属化合物量子点、其制备方法及应用 |
CN114163989A (zh) * | 2020-09-11 | 2022-03-11 | 北京大学 | 一种银的硫族化合物-碳化铁异质纳米结构及其制备方法和应用 |
CN112266009B (zh) * | 2020-10-26 | 2022-03-25 | 中国科学院兰州化学物理研究所 | 一种超小硫化银量子点的制备方法 |
CN112251134B (zh) * | 2020-10-26 | 2021-12-31 | 中国科学院兰州化学物理研究所 | 一种硫化银量子点增强粘结固体润滑涂料及涂层 |
CN113237934B (zh) * | 2021-05-24 | 2024-04-09 | 常州大学 | 一种可用于电化学发光手性识别的手性硫化银量子点/少层氮化碳复合物及其制备方法 |
CN113563887B (zh) * | 2021-07-26 | 2022-06-28 | 南开大学 | 一种Ag2Te量子点尺寸调控的方法 |
CN114324520B (zh) * | 2021-12-20 | 2023-07-04 | 济南大学 | 基于硫化银增强ptca谷胱甘肽检测的光电化学传感器的制备方法 |
CN115252876B (zh) * | 2022-07-27 | 2023-11-24 | 青岛大学 | 一种单分散发光显影载药四合一栓塞微球及其制备方法 |
CN116970387B (zh) * | 2023-07-25 | 2024-05-10 | 南京邮电大学 | 一种检测水解奶粉的复合纳米材料及其制备方法与应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101508416A (zh) * | 2009-03-11 | 2009-08-19 | 上海大学 | 巯基单或多元有机酸表面修饰的ⅱ-ⅵ族半导体量子点及其制备方法 |
CN101805606A (zh) * | 2010-02-22 | 2010-08-18 | 中国科学院苏州纳米技术与纳米仿生研究所 | 一种单分散近红外量子点的制备方法 |
CN102277157A (zh) * | 2011-05-30 | 2011-12-14 | 中国科学院苏州纳米技术与纳米仿生研究所 | 近红外硫化银量子点、其制备方法及其应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2001275078A1 (en) * | 2000-06-01 | 2001-12-11 | The Board Of Regents For Oklahoma State University | Bioconjugates of nanoparticles as radiopharmaceuticals |
US7507530B2 (en) * | 2002-08-27 | 2009-03-24 | E. I. Du Pont De Nemours And Company | Nanoparticle complexes having a defined number of ligands |
JP5682902B2 (ja) * | 2008-04-23 | 2015-03-11 | 独立行政法人産業技術総合研究所 | 水分散性を有する高発光効率ナノ粒子 |
JP5392743B2 (ja) * | 2008-05-19 | 2014-01-22 | 独立行政法人理化学研究所 | 水溶性近赤外蛍光材料およびマルチモーダル水溶性近赤外蛍光材料 |
CN101723311B (zh) * | 2009-11-06 | 2012-03-07 | 武汉理工大学 | 磁-光传感器用磁性荧光纳米材料及其制备方法 |
CN101857276A (zh) * | 2010-06-21 | 2010-10-13 | 中国科学院苏州纳米技术与纳米仿生研究所 | 一种通用纳米金属硫化物的制备方法 |
-
2011
- 2011-05-30 CN CN201110142093.8A patent/CN102277157B/zh active Active
-
2012
- 2012-02-10 US US13/985,731 patent/US20140087409A1/en not_active Abandoned
- 2012-02-10 JP JP2014511707A patent/JP5815126B2/ja active Active
- 2012-02-10 EP EP12793905.6A patent/EP2716733B1/en active Active
- 2012-02-10 WO PCT/CN2012/000167 patent/WO2012163078A1/zh active Application Filing
- 2012-02-10 RU RU2013152134/05A patent/RU2576052C2/ru active
-
2015
- 2015-12-01 US US14/955,736 patent/US10421901B2/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101508416A (zh) * | 2009-03-11 | 2009-08-19 | 上海大学 | 巯基单或多元有机酸表面修饰的ⅱ-ⅵ族半导体量子点及其制备方法 |
CN101805606A (zh) * | 2010-02-22 | 2010-08-18 | 中国科学院苏州纳米技术与纳米仿生研究所 | 一种单分散近红外量子点的制备方法 |
CN102277157A (zh) * | 2011-05-30 | 2011-12-14 | 中国科学院苏州纳米技术与纳米仿生研究所 | 近红外硫化银量子点、其制备方法及其应用 |
Non-Patent Citations (2)
Title |
---|
"Near-infrared photoluminescent Ag2S quantum dots from a single source precursor", J. AM. CHEM. SOC., vol. 132, 2010, pages 1470 |
See also references of EP2716733A4 * |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016024924A1 (en) | 2014-08-13 | 2016-02-18 | Koç Üni̇versi̇tesi̇ | Near-ir emitting cationic silver chalcogenide quantum dots |
US10138419B2 (en) | 2014-08-13 | 2018-11-27 | Koç Üniversitesi | Near-IR emitting cationic silver chalcogenide quantum dots |
US11015115B2 (en) | 2015-12-31 | 2021-05-25 | 3M Innovative Properties Company | Curable quantum dot compositions and articles |
US11015114B2 (en) | 2015-12-31 | 2021-05-25 | 3M Innovative Properties Company | Article comprising particles with quantum dots |
WO2021070858A1 (ja) * | 2019-10-09 | 2021-04-15 | Nsマテリアルズ株式会社 | 量子ドット、及び、その製造方法 |
CN110940718A (zh) * | 2019-12-10 | 2020-03-31 | 集美大学 | 一种近红外光电Ag2S@Au立方材料的制备和测试方法 |
CN110940718B (zh) * | 2019-12-10 | 2022-04-01 | 集美大学 | 一种近红外光电Ag2S@Au立方材料的制备和测试方法 |
CN111087011A (zh) * | 2019-12-16 | 2020-05-01 | 上海电力大学 | 一种硫化银量子点和硫化铟银量子点纳米材料的制备方法及其产品 |
Also Published As
Publication number | Publication date |
---|---|
EP2716733A1 (en) | 2014-04-09 |
US20140087409A1 (en) | 2014-03-27 |
CN102277157B (zh) | 2014-06-11 |
JP5815126B2 (ja) | 2015-11-17 |
EP2716733A4 (en) | 2014-12-24 |
JP2014522484A (ja) | 2014-09-04 |
RU2013152134A (ru) | 2015-07-10 |
CN102277157A (zh) | 2011-12-14 |
RU2576052C2 (ru) | 2016-02-27 |
EP2716733B1 (en) | 2016-10-26 |
US10421901B2 (en) | 2019-09-24 |
US20160083647A1 (en) | 2016-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2012163078A1 (zh) | 一种近红外硫化银量子点、其制备方法及其生物应用 | |
CN103121705B (zh) | CuS纳米粒子的制备方法、其产品及应用 | |
Kim et al. | Highly fluorescent CdTe quantum dots with reduced cytotoxicity-A Robust biomarker | |
JP2009107106A (ja) | 不規則な表面構造の早期導入により高収率のバイオイメージングナノ粒子を製造する方法 | |
CA2735011A1 (en) | Quantum dots, methods of making quantum dots, and methods of using quantum dots | |
Chen et al. | Synthesis of ribonuclease-A conjugated Ag2S quantum dots clusters via biomimetic route | |
Mansur et al. | Biomolecule-quantum dot systems for bioconjugation applications | |
CN107158378B (zh) | 一种光热效应用硫化铜锰蛋白复合纳米颗粒及其制备方法 | |
HUE030777T2 (en) | Nanoaggregates with a molecular ultra-small set of precious metals and a process for their production | |
CN114346253B (zh) | 一种银纳米簇-钯复合纳米片的制备方法及其产品和应用 | |
CN106520123A (zh) | 一种银硒硫量子点纳米颗粒的制备方法 | |
CN105000588A (zh) | 一种水溶性硫化铜量子点的制备方法 | |
Venkatachalam et al. | Aqueous CdTe colloidal quantum dots for bio-imaging of Artemia sp | |
Daramola et al. | Synthesis of pH sensitive dual capped CdTe QDs: their optical properties and structural morphology | |
EP4122886A1 (en) | Complex between silicate-based substrate and rare earth element compound, light-emitting nano particles, cell detection method, animal treatment method, medical device, and method for producing complex between silicate-based substrate and rare earth element compound | |
Sharma et al. | Review on synthesis, characterization and applications of silver sulphide quantum dots | |
Mahesh et al. | New paradigms for the synthesis of graphene quantum dots from sustainable bioresources | |
Bhanoth et al. | Biotoxicity of CdS/CdSe Core-Shell Nano-Structures | |
Vijayaraj et al. | Fluorescence imaging of onion epidermal cell utilizing highly luminescent water-soluble CdTe colloidal quantum dots | |
CN112268882B (zh) | 一种高选择性检测谷胱甘肽的碳点-二氧化锰纳米荧光探针的制备方法及其应用 | |
KR100943993B1 (ko) | 나노 복합체 및 이의 제조 방법 | |
CN104830322A (zh) | 一种高稳定性的近红外水溶性CuS荧光量子点的制备方法 | |
CN111004628B (zh) | 核壳结构硫属化合物量子点、其制备方法及应用 | |
KR101413158B1 (ko) | 양자점의 표면 개질 방법과 이를 이용한 생체 광학영상화 | |
Mertoğlu | The synthesis and characterization of thioglycolic acid and thiourea capped fluorescent zinc sulfide nanoparticles |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12793905 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13985731 Country of ref document: US |
|
REEP | Request for entry into the european phase |
Ref document number: 2012793905 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2012793905 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2014511707 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2013152134 Country of ref document: RU Kind code of ref document: A |